NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts
- PMID: 19262012
- DOI: 10.2152/jmi.56.33
NADPH oxidase-derived reactive oxygen species are essential for differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts
Abstract
Reactive oxygen species (ROS) derived from NADPH oxidase (Nox) homologues have been suggested to regulate osteoclast differentiation. However, no bone abnormalities have been documented in Nox1 deficient, Nox2 deficient, or Nox3 mutant mice. During receptor activator of nuclear factor-kappaB ligand (RANKL)-stimulated differentiation of a mouse macrophage cell line (RAW264.7) into osteoclasts, mRNA levels of Nox enzymes (Nox1-4) and their adaptor proteins were monitored by real-time reverse transcriptase PCR. RAW264.7 cells constitutively expressed abundant Nox2 mRNA and small amounts of Nox1 and Nox3 transcripts. RANKL markedly attenuated Nox2 mRNA expression in association with reciprocal up-regulation of Nox1 and Nox3 transcripts. Introduction of small interference RNA targeting p67(phox) or p22(phox) into RAW264.7 cells effectively down-regulated ROS generation and significantly suppressed the RANKL-stimulated differentiation, which was assessed by appearance of tartrate resistant acid phosphatase (TRAP)-positive, multinucleated cells having an ability to form resorption pits on calcium phosphate thin film-coated disks, and by expression of osteoclast marker genes (TRAP, cathepsin K, Atp6i, ClC-7, and NFATc1). Our results suggest that RANKL may stimulate switching between Nox homologues during osteoclast differentiation, and Nox-derived ROS may be crucial for RANKL-induced osteoclast differentiation.
Similar articles
-
Receptor activator of nuclear factor-kappaB ligand-induced mouse osteoclast differentiation is associated with switching between NADPH oxidase homologues.Free Radic Biol Med. 2009 Jul 15;47(2):189-99. doi: 10.1016/j.freeradbiomed.2009.04.025. Epub 2009 May 3. Free Radic Biol Med. 2009. PMID: 19409483
-
Platinum nanoparticles suppress osteoclastogenesis through scavenging of reactive oxygen species produced in RAW264.7 cells.J Pharmacol Sci. 2011;117(4):243-52. doi: 10.1254/jphs.11099fp. Epub 2011 Nov 12. J Pharmacol Sci. 2011. PMID: 22083043
-
A crucial role for reactive oxygen species in RANKL-induced osteoclast differentiation.Blood. 2005 Aug 1;106(3):852-9. doi: 10.1182/blood-2004-09-3662. Epub 2005 Apr 7. Blood. 2005. PMID: 15817678
-
Targeting and regulation of reactive oxygen species generation by Nox family NADPH oxidases.Antioxid Redox Signal. 2009 Oct;11(10):2607-19. doi: 10.1089/ars.2009.2637. Antioxid Redox Signal. 2009. PMID: 19438290 Free PMC article. Review.
-
Combating oxidative stress in vascular disease: NADPH oxidases as therapeutic targets.Nat Rev Drug Discov. 2011 Jun;10(6):453-71. doi: 10.1038/nrd3403. Nat Rev Drug Discov. 2011. PMID: 21629295 Free PMC article. Review.
Cited by
-
Oregano Essential Oil Attenuates RAW264.7 Cells from Lipopolysaccharide-Induced Inflammatory Response through Regulating NADPH Oxidase Activation-Driven Oxidative Stress.Molecules. 2018 Jul 26;23(8):1857. doi: 10.3390/molecules23081857. Molecules. 2018. PMID: 30049950 Free PMC article.
-
Inhibitory Effects of Rhaponticin on Osteoclast Formation and Resorption by Targeting RANKL-Induced NFATc1 and ROS Activity.Front Pharmacol. 2021 Sep 23;12:645140. doi: 10.3389/fphar.2021.645140. eCollection 2021. Front Pharmacol. 2021. PMID: 34630071 Free PMC article.
-
NADPH oxidase 4 represents a potential target for the treatment of osteoporosis.Cell Mol Immunol. 2014 Jul;11(4):317-9. doi: 10.1038/cmi.2014.9. Epub 2014 Mar 3. Cell Mol Immunol. 2014. PMID: 24583714 Free PMC article. No abstract available.
-
Molecular regulatory mechanisms of osteoclastogenesis through cytoprotective enzymes.Redox Biol. 2016 Aug;8:186-91. doi: 10.1016/j.redox.2016.01.006. Epub 2016 Jan 11. Redox Biol. 2016. PMID: 26795736 Free PMC article. Review.
-
Reactive oxygen species and oxidative stress in osteoclastogenesis, skeletal aging and bone diseases.J Bone Miner Metab. 2015 Jul;33(4):359-70. doi: 10.1007/s00774-015-0656-4. Epub 2015 Mar 26. J Bone Miner Metab. 2015. PMID: 25804315 Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous